APLEX Bio

Aplex Bio is a Swedish biotechnology company developing advanced molecular testing solutions designed to overcome limitations in current PCR and NGS methods by enabling high-throughput detection of numerous targets with single-nucleotide resolution. The firm creates technologies that allow labs to analyze large sample volumes efficiently without requiring substantial equipment investments or facing prohibitive operational costs.

• Innovation: The company utilizes Nanopixels™, padlock probes, and RCA-based molecular counting to achieve ultra-sensitive endpoint quantitative PCR capable of detecting over 100 targets per well.
• Industries: Their solutions are engineered to support impactful decision-making in healthcare diagnostics and sustainability sectors by providing deeper insights into biological systems.
• Locations: Aplex Bio is headquartered at the Karolinska Science Park on Nobels Väg 16 in Solna, Sweden.

These capabilities empower researchers to generate better knowledge about biological systems for improved therapies without compromising on sensitivity or specificity.